Amrutanjan Health Care Limited

rs,

ex, Bandra (E) Mumbai 400 051 BSE Limited Department of Corporate Services 1st Floor, PJ. Towers, Dalal Street, Mumbai 400 001 Symbol : AMRUTANJAN Scrip Code: 590006 Dear Sir / Madam, Sub:

Rs.191

uarter & Year Ended 31st March 2021 4 Business Update • Cash reserve as on 31st March 2021 is at Rs.191 crs (Rs.105 crs as on 31st March 2020) • Continue to be a ”No debt company” Investor Presentation

Rs.105

r Ended 31st March 2021 4 Business Update • Cash reserve as on 31st March 2021 is at Rs.191 crs (Rs.105 crs as on 31st March 2020) • Continue to be a ”No debt company” Investor Presentation | Quarter &

27.29%

arch 2021 6 Financials – FY21 (Rs. in Crores) Gross Sales 367.78 288.92 FY21 FY20 Growth: 27.29% Gross Sales - E Comm. 4.43 Profit Before Tax 81.90 34.45 FY21 FY20 Growth: 137.74% Prof

137.74%

rowth: 27.29% Gross Sales - E Comm. 4.43 Profit Before Tax 81.90 34.45 FY21 FY20 Growth: 137.74% Profit After Tax 61.19 1.58 25.08 FY21 FY20 Growth: 180.38% FY21 FY20 Growth: 143.98%

180.38%

34.45 FY21 FY20 Growth: 137.74% Profit After Tax 61.19 1.58 25.08 FY21 FY20 Growth: 180.38% FY21 FY20 Growth: 143.98% Investor Presentation | Quarter & Year Ended 31st March 2021 7 Fina

143.98%

137.74% Profit After Tax 61.19 1.58 25.08 FY21 FY20 Growth: 180.38% FY21 FY20 Growth: 143.98% Investor Presentation | Quarter & Year Ended 31st March 2021 7 Financials – FY21 – OTC Division

30.33%

als – FY21 – OTC Division (Rs. in Crores) Gross Sales - OTC 346.75 266.05 FY21 FY20 Growth: 30.33% Gross Sales - Comfy 54.36 39.99 FY21 FY20 Growth: 35.93% Costs: • OTC sales has grown by

35.93%

.75 266.05 FY21 FY20 Growth: 30.33% Gross Sales - Comfy 54.36 39.99 FY21 FY20 Growth: 35.93% Costs: • OTC sales has grown by 30.33% for FY21 even though in Q1 sales was affected due to Cov

229 basis point

terial prices including Menthol are lower when compared to FY20. • Gross Margin has improved by 229 basis points when compared to FY20. • Advertisement spend for FY21 is Rs.26.52 cr against Rs.32.66 cr for F

Rs.26.52

argin has improved by 229 basis points when compared to FY20. • Advertisement spend for FY21 is Rs.26.52 cr against Rs.32.66 cr for FY20. Investor Presentation | Quarter & Year Ended 31st March 2021 8

Rs.32.66

y 229 basis points when compared to FY20. • Advertisement spend for FY21 is Rs.26.52 cr against Rs.32.66 cr for FY20. Investor Presentation | Quarter & Year Ended 31st March 2021 8 Financials – FY21 –

Costs

2

DocuSigned by

1

We remain focused on executing our key priorities

1

DocuSigned by

[ Srinivasan M B1B2BB667E1745F. (M Srinivasan) Company Secretary & Compliance Officer Amrutanjan Health Care Limited Investor Presentation – Quarter & Year Ended 31st March 2021 Date: 27th May 2021 Contents a. Business Update b. FY21 Performance c. Q4 FY21 Performance d. Way Forward Investor Presentation | Quarter & Year Ended 31st March 2021 2 Business Update Investor Presentation | Quarter & Year Ended 31st March 2021 3 Business Update • Despite restrictions for field force during lockdown, our wholesale channel was picking up. This shows our Brand strength. • The increase in purchase volume by the distributors has contributed to the growth factor. • Consumers’ current preference of Balms over Tablets remains to be seen for its longevity. • Demand continues to grow for our core products – Balms & Women Hygiene (Comfy). • Some consumers reportedly using our balms for steam inhalation. • Our Health Drink - Electro+ with Vitamin-C content is an area identified for brand investments in f

Costs

• OTC sales has grown by 30.33% for FY21 even though in Q1 sales was affected due to Covid 19 lockdown. • Key raw material prices including Menthol are lower when compared to FY20. • Gross Margin has improved by 229 basis points when compared to FY20. • Advertisement spend for FY21 is Rs.26.52 cr against Rs.32.66 cr for FY20. Investor Presentation | Quarter & Year Ended 31st March 2021 8 Financials – FY21 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 20.45 19.51 FY21 FY20 Growth: -4.60% Gross Sales - Electro Plus 12.82 7.93 FY21 FY20 Growth: 61.66%

Costs

• Gross Margin has improved by 855 basis points when compared to FY20 mainly due to product mix. • Advertisement spends is Rs.3.10 cr for FY21 against Rs.0.81 cr for FY20. • Business is continuing with cash & carry model for Fruitnik. Investor Presentation | Quarter & Year Ended 31st March 2021 9 Key Financial Ratios 40.00% 35.00% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% 16.00 14.00 12.00 10.00 8.00 6.00 4.00 2.00 0.00 Return on Capital Employed % Operating Profit Margin (%) 37.09% 20.85% 24.76% 13.26% 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% FY21 FY20 FY21 FY20 Debtors Turnover Ratio Inventory Turnover Ratio 15.09 8.80 16.17 13.66 16.50 16.00 15.50 15.00 14.50 14.00 13.50 13.00 12.50 12.00 FY21 FY20 FY21 FY20 Investor Presentation | Quarter & Year Ended 31st March 2021 10 Q4 FY21 Performance Investor Presentation | Quarter & Year Ended 31st March 2021 11 Financials – Q4 FY21 (Rs. in Crores) Gross Sales 104.74 66.20 Profit Before Tax 13.71 Profit After Tax 10.23 10.64 7.89

We remain focused on executing our key priorities

• Expand distribution • Grow E-Commerce vertical • Strengthen Beverage business • Costs control Investor Presentation | Quarter & Year Ended 31st March 2021 15 Investor Presentation | Quarter & Year Ended 31st March 2021 16